NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
Clinical Trials
34 trialsNCT03445858 2026-02-18
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Completed
NCT03433898 2025-12-19
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
Boehringer Ingelheim
Phase EARLY_PHASE1 Completed
NCT04495751 2025-10-16
Muscadine Grape Extract to Improve Fatigue
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT04185337 2025-02-27
Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT05128838 2025-02-05
RISE (Reinvent, Integrate, Strengthen, Expand) Self-Management Program for Cancer Survivors: A Feasibility Study
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT03153410 2025-01-09
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT05716113 2024-11-21
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL
Zhejiang University
Phase EARLY_PHASE1 Completed
NCT05902845 2024-11-21
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL
Anhui Provincial Hospital
Phase EARLY_PHASE1 Completed
NCT05907603 2024-11-21
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)
Xuzhou Medical University
Phase EARLY_PHASE1 Completed
NCT04522804 2024-03-20
HOPE
University of Utah
Phase EARLY_PHASE1 Completed
NCT04509167 2024-03-06
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms
Instituto de Medicina Regenerativa
Phase EARLY_PHASE1 Completed
NCT05029596 2023-09-21
Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT04936997 2022-05-20
Immune Response to the COVID-19 Vaccine
University of Arizona
Phase EARLY_PHASE1 Completed
NCT04882111 2021-11-11
ALIGN
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT02181478 2020-12-04
Intra-Osseous Co-Transplant of UCB and hMSC
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00957359 2020-10-20
Psilocybin Cancer Anxiety Study
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT00013533 2019-12-16
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT00214422 2019-07-19
Intensity Modulated Radiation Therapy for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02285738 2019-05-08
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02836288 2018-11-06
Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT01132014 2018-06-11
Autologous OC-DC Vaccine in Ovarian Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT01725048 2017-03-13
NRR
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01634126 2016-09-16
MY-FIT
Kaiser Permanente
Phase EARLY_PHASE1 Completed
NCT01678690 2016-09-02
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
InnoPharmax Inc.
Phase EARLY_PHASE1 Completed
NCT01160302 2016-03-02
Curcumin Biomarker Trial in Head and Neck Cancer
Louisiana State University Health Sciences Center Shreveport
Phase EARLY_PHASE1 Completed
NCT00580788 2016-02-11
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT00874861 2015-12-08
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT01827618 2015-07-02
Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT01417065 2014-06-23
Temsirolimus In Phase 0
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01513356 2014-04-02
Pharmacodynamic Study of BKM120 in Breast Cancer
Grupo Hospital de Madrid
Phase EARLY_PHASE1 Completed
NCT01835509 2014-02-25
Group Intervention to Increase Physical Activity in Childhood Cancer Survivors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT00440570 2011-06-29
THBC001
Pasche, Boris, M.D.
Phase EARLY_PHASE1 Completed
NCT00402753 2010-01-07
Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients
University of Zurich
Phase EARLY_PHASE1 Completed